Lefamulin is a novel antibiotic that has recently gained attention for its effectiveness in treating community-acquired bacterial pneumonia (CABP). As antibiotic resistance continues to rise ...
We studied all patients with community-acquired pneumonia who were admitted to our 800-bed adult acute care hospital from 1 November 1981 to 15 March 1987. The 719 patients had a mean age of 63.2 ...
The Indian drug regulator, Central Drugs Standard Control Organization (CDSCO) has approved Miqnaf (nafithromycin) as a new treatment for the Community-Acquired Bacterial Pneumonia (CABP) in Adults ...
Antibiotics are not meant to treat a viral illness, it has long been known in the medical community ... taking antibiotics will develop a bacterial pneumonia rather than avoid one, the researchers ...